Evidence map›Paper›PMID 33138675›Full record

ArticleRNA biology2021

Xrn1 influence on gene transcription results from the combination of general effects on elongating RNA pol II and gene-specific chromatin configuration.

Victoria Begley, Antonio Jordán-Pla, Xenia Peñate, Ana I Garrido-Godino, Drice Challal, Abel Cuevas-Bermúdez, Adrià Mitjavila, Mara Barucco, Gabriel Gutiérrez, Abhyudai Singh and 5 more

Open access · greenAbstract read
In one paragraph

Article in RNA biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Enhanced gene regulation by cooperation between mRNA decay and gene transcription.Biochimica et biophysica acta. Gene regulatory mechanisms · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Victoria BegleyInstituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. Del Rocío, Seville, Spain.
Antonio Jordán-PlaInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València; Burjassot, Valencia, Spain.
Xenia PeñateInstituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. Del Rocío, Seville, Spain.
Ana I Garrido-GodinoDepartamento de Biología Experimental, Facultad de Ciencias Experimentales, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-7389-1372
Drice ChallalInstitut Jacques Monod, Centre National De La Recherche Scientifique, UMR 7592, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Abel Cuevas-BermúdezDepartamento de Biología Experimental, Facultad de Ciencias Experimentales, Universidad de Jaén, Jaén, Spain.
Adrià MitjavilaInstituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. Del Rocío, Seville, Spain.
Mara BaruccoInstitut Jacques Monod, Centre National De La Recherche Scientifique, UMR 7592, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Gabriel GutiérrezDepartamento de Genética, Facultad de Biología, Universidad de Sevilla, Seville, Spain.
Abhyudai SinghDepartment of Electrical and Computer Engineering, University of Delaware, Newark, Delaware, USA.
Paula AlepuzInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València; Burjassot, Valencia, Spain.ORCID 0000-0003-1472-2373
Francisco NavarroDepartamento de Biología Experimental, Facultad de Ciencias Experimentales, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-4180-422X
Domenico LibriInstitut Jacques Monod, Centre National De La Recherche Scientifique, UMR 7592, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
José E Pérez-OrtínInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València; Burjassot, Valencia, Spain.ORCID 0000-0002-1992-513X
Sebastián ChávezInstituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. Del Rocío, Seville, Spain.ORCID 0000-0002-8064-4839
Instituto de Biomedicina de Sevilla · ESDélégation Paris 7 · FRUniversidad de Jaén · ESUniversitat de València · ESUniversidad de Sevilla · ESUniversity of Delaware · US

Funding

Consequences and Control of Randomness in Timing of Intracellular EventsR01GM124446 · NIGMS · UNIVERSITY OF DELAWARE · PI SINGH, ABHYUDAI · 2017 to 2020
$914k
Stochastic hybrid systems approach to uncovering cell-size control mechanisms R01GM126557 · NIGMS · UNIVERSITY OF DELAWARE · PI SINGH, ABHYUDAI · 2017 to 2019
$675k
NIGMS NIH HHS R01 GM124446NIGMS NIH HHS R01 GM126557
6 · The paper itself

Abstract

mRNA homoeostasis is favoured by crosstalk between transcription and degradation machineries. Both the Ccr4-Not and the Xrn1-decaysome complexes have been described to influence transcription. While Ccr4-Not has been shown to directly stimulate transcription elongation, the information available on how Xrn1 influences transcription is scarce and contradictory. In this study we have addressed this issue by mapping RNA polymerase II (RNA pol II) at high resolution, using CRAC and BioGRO-seq techniques in

Indexed as

Transcription Elongation, GeneticChromatinExoribonucleasesGene Expression Regulation, FungalNucleosomesRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscriptional Elongation FactorsChromatinExoribonucleasesNucleosomesRNA Polymerase IISaccharomyces cerevisiae ProteinsTranscriptional Elongation FactorsXRN1 protein, S cerevisiae3ʹ pre-mRNA processingmRNA bufferingmRNA decaymRNA decay/gene transcription crosstalkTranscription elongationXrn1

Identifiers

PMID33138675
PMCPMC8354610
OpenAlexW3095494555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.